The Second Revision of the Dopamine Theory of Schizophrenia: Implications for Treatment and Drug Development
Author:
- 1 July 2013
- journal article
- editorial
- Published by Elsevier in Biological Psychiatry
- Vol. 74 (2) , 80-81
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second CohortBiological Psychiatry, 2013
- The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for TreatmentArchives of General Psychiatry, 2012
- Predicting PsychosisArchives of General Psychiatry, 2012
- Increased Synaptic Dopamine Function in Associative Regions of the Striatum in SchizophreniaArchives of General Psychiatry, 2010
- Elevated Striatal Dopamine Function Linked to Prodromal Signs of SchizophreniaArchives of General Psychiatry, 2009
- Glutamate, Dopamine, and SchizophreniaAnnals of the New York Academy of Sciences, 2003
- Reevaluation of the Mesolimbic Hypothesis of Antipsychotic Drug ActionSchizophrenia Bulletin, 1995
- Dopamine in schizophrenia: a review and reconceptualizationAmerican Journal of Psychiatry, 1991
- Implications of Normal Brain Development for the Pathogenesis of SchizophreniaArchives of General Psychiatry, 1987
- An Anatomy of Schizophrenia?Archives of General Psychiatry, 1973